SCHEMBL19624971

SCHEMBL19624971

CC(=O)c1ccc(-n2cc3cc(C)ccc3n2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.47
GCG P01275 2/20 0.47
ESR2 Q92731 1/20 0.46
MAPT P10636 4/20 0.45
LMNA P02545 2/20 0.45
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
MEN1 O00255 1/20 0.45
NFKB1 P19838 1/20 0.45
CASP3 P42574 1/20 0.45
NFKB2 Q00653 1/20 0.45
KMT2A Q03164 1/20 0.45
RELA Q04206 1/20 0.45
SENP8 Q96LD8 1/20 0.45
SENP7 Q9BQF6 1/20 0.45
SENP6 Q9GZR1 1/20 0.45
KCNJ1 P48048 1/20 0.44
HTT P42858 1/20 0.43
TSHR P16473 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1665673 0.84 ESR2 (0.44) GCGESR2MAPTLMNANPC1
SCHEMBL2270216 0.81 KCNJ1 (0.47) GCGESR2MAPTNPC1RAB9A
SCHEMBL19763361 0.80 TDP1 (0.49) GCGESR2MAPTLMNANPC1
SCHEMBL18470549 0.79 ESR2 (0.46) GCGESR2MAPTLMNANPC1
SCHEMBL13492786 0.79 ESR2 (0.66) ESR2MAPTLMNANPC1RAB9A
SCHEMBL26442788 0.77 ESR2 (0.47) GCGESR2MAPTLMNANPC1
SCHEMBL18470552 0.75 ESR2 (0.43) GCGESR2MAPTLMNANPC1
SCHEMBL13015506 0.74 MEN1 (0.49) ESR2NPC1SMN1; SMN2MEN1KMT2A
SCHEMBL28541087 0.73 MEN1 (0.49) GCGESR2MAPTLMNANPC1
SCHEMBL28967464 0.73 MEN1 (0.49) GCGESR2MAPTLMNANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3246317-B1 BTK INHIBITOR HUBEI BIO PHARMACEUTICAL INDUSTRIAL TECH INSTITUTE INC (CN) 2023-02-22 EP disclosed
EP-3246317-A1 BTK INHIBITOR Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. (CN) 2017-11-22 EP disclosed